Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2836
www.abbvie.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc.
AbbVie Secures FDA Approval to Expand Mavyret’s Label
- Jun 13th, 2025 2:18 pm
FDA approves label expansion of AbbVie hepatitis C therapy
- Jun 13th, 2025 2:28 am
Senators Propose Ban on Drug Advertising to Consumers
- Jun 12th, 2025 1:41 pm
AbbVie (NYSE:ABBV) Achieves FDA Approval for MAVYRET Label Expansion to Treat Pediatric Hepatitis C
- Jun 12th, 2025 11:53 am
AbbVie (ABBV) Gains As Market Dips: What You Should Know
- Jun 11th, 2025 3:45 pm
FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)
- Jun 11th, 2025 3:07 pm
U.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus
- Jun 11th, 2025 10:31 am
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
- Jun 11th, 2025 7:00 am
Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?
- Jun 10th, 2025 7:02 am
1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of
- Jun 8th, 2025 10:37 pm
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
- Jun 8th, 2025 4:35 am
Challenges pharma companies face in push into US manufacturing
- Jun 6th, 2025 2:16 pm
Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?
- Jun 6th, 2025 7:12 am
AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
- Jun 5th, 2025 3:45 pm
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
- Jun 5th, 2025 6:00 am
AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?
- Jun 4th, 2025 10:02 pm
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
- Jun 4th, 2025 8:31 am
3 Cheap Dividend Growth Stocks to Buy Right Now
- Jun 4th, 2025 3:50 am
ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons
- Jun 3rd, 2025 10:09 am
AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals
- Jun 3rd, 2025 6:15 am
Scroll